VNRX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 16:41):

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide...

Stats
Dzisiejszy wolumen	3 735.00
Średni wolumen	187 032
Kapitalizacja rynkowa	72.20M
EPS	$-0.110 ( 2024-03-26 )
Następna data zysków	( $-0.110 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.760
ATR14	$0.00500 (0.58%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-19	Retter Andrew	Sell	0	No securities are beneficially owned
2024-01-24	Forterre Gael	Buy	25 925	Common Stock
2024-01-24	Michel Gaetan	Buy	42 925	Common Stock
2024-01-24	Innes Guy Archibald	Buy	8 500	Common Stock
2024-01-24	Micallef Jacob Vincent	Buy	23 375	Common Stock

INSIDER POWER
45.09
Last 100 transactions
Buy: 2 825 718 \| Sell: 1 112 036

Wolumen Korelacja

Długi: 0.13 (neutral)

Krótki: -0.59 (weak negative)

Signal:(27.146) Neutral

VolitionRX Ltd Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

VolitionRX Ltd Korelacja - Waluta/Towar

-0.18
( neutral )

-0.25
( neutral )

0.00
( neutral )

-0.18
( neutral )

0.12
( neutral )

VolitionRX Ltd Finanse

Annual	2023
Przychody:	$775 302
Zysk brutto:	$-636 325 (-82.07 %)
EPS:	$-0.500

FY	2023
Przychody:	$775 302
Zysk brutto:	$-636 325 (-82.07 %)
EPS:	$-0.500

FY	2022
Przychody:	$306 392
Zysk brutto:	$-882 029 (-287.88 %)
EPS:	$-0.550

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$0.000707

Financial Reports:

No articles found.

VolitionRX Ltd

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.

Aktualne aktualizacje dla VolitionRX Ltd [VNRX]

Upcoming Earnings Alert